Research for a life without cancer
At the DKFZ, we want to ensure that fewer people develop cancer, that cancer can be cured or treated so effectively that those affected can live with the disease and grow old with a good quality of life.
About DKFZ
 
 
 
 
 
 
 
 
 Latest from DKFZ
 Ependymomas, brain tumors that occur particularly in young children, are especially difficult to treat and more than half of the children affected have an increased risk of relapse. As part of an international consortium, the Hopp Children's Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ), the Medical Faculty of Heidelberg University (MFHD) and Heidelberg University Hospital (UKHD) have received a grant of 1.5 million pounds sterling (GBP) from the British organization The Brain Tumor Charity to develop a new type of immunotherapy for ependymoma. The Hopp Children’s Cancer Center Heidelberg (KiTZ) is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD) and the University of Heidelberg (Uni HD).
 
 
 
 
 
 
 Our research opens doors in the fight against cancer
 
 Do you have questions on the topic of cancer?
Let us advise you!
Doctors from the Cancer Information Service answer your questions every day. Find out more now for free!